Case Details

Year Initiated/Committed

2009

Year Resolved

2010

Settlement Amount

$25 million

Court

U.S. District Court for the District of Columbia

Docket Number

1:09-cv-02112-TFH

Lead State

NY

Participating States

AZ, DC, FL, HI, ID, IL, KS, ME, MI, MN, NC, ND, NM, NV, NY, PR, RI, SD, TN, VT, WA, WI, WV

Defendant(s)

AKZO NOBEL INC., BIOPRODUCTS INCORPORATED, MITSUI & CO., LTD., MITSUI & CO., (U.S.A.), INC., CHINOOK GLOBAL LIMITED, CHINOOK GROUP, INC., EVONIK DEGUSSA GMBH, DEGUSSA CORPORATION, LONZA AG, MERCK KGAA, E. MERCK OHG, EMD CHEMICALS INC., NEPERA, INC., SUMITOMO CHEMICAL AMERICA, INC., SUMITOMO CHEMICAL CO., LTD., MITSUBISHI TANABE PHARMA CORPORATION, TANABE U.S.A., INC., UCB PHARMA, INC., VERTELLUS SPECIALTIES INC., VERTELLUS CHEMICALS SA (dr)

Case Description

As part of a private class action lawsuit, states, as parens patriae for their citizens, reached a settlement with vitamin manufacturers accused of fixing prices on certain vitamins (The vitamins affected by this alleged price fixing conspiracy are: vitamin A,
astaxanthin, vitamin B1 (thiamin), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B4 (choline chloride), vitamin B5 (calpan), vitamin B6, vitamin B9 (folic acid), vitamin B12 (cyanocobalamine pharma), betacarotene, vitamin C, canthaxanthin, vitamin E, and vitamin H (biotin), as well as all blends and forms of these vitamins) sold purchased between 1988 and 2000. This case is related to the case New York et al. v. Hoffmann-LaRoche, Inc.,et al. with different defendants..